Stifel analyst Brian Chin lowered the firm’s price target on Teradyne (TER) to $110 from $125 and keeps a Hold rating on the shares. Teradyne’s cautious nearer-term outlook “did steal some spotlight from discussion of the mid-to-longer term strategy,” though the firm exited the company’s analyst day with a better understanding of how Teradyne is positioning itself for share gains, the analyst tells investors in a recap of the event. The firm lowered its 2025 estimates, but notes that restructuring actions may help ensure that the drag on EPS is reduced amid the current uncertainty if growth underperforms.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne price target lowered to $140 from $150 at KeyBanc
- Teradyne price target lowered to $85 from $100 at BofA
- Teradyne Positioned for Growth Amid Industry Trends and Strategic Acquisitions
- Teradyne’s Revised Guidance and Trade Uncertainties Prompt Sell Rating by Analyst Shane Brett
- Cautious Outlook on Teradyne Amid Macroeconomic Challenges and Ambitious Growth Targets
Questions or Comments about the article? Write to editor@tipranks.com